The bad news is, good news for the biotech sector doesn’t necessarily translate to an uptick for the genomics industry.
A group of investors believes the biotech sector is ready for a turnaround — so much so that they have launched a new fund called InvestBio. “This remains one of the big growth sectors,” says fund co-manager Libbe Englander of Diversified Biotech Group.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
